Beijing Geekgene Technology Co., Ltd
Clinical trials sponsored by Beijing Geekgene Technology Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Experimental cell therapy takes on advanced cancers Results expected Dec 2026 (estimated)
- Can immune cells from belly fluid fight advanced cancer? Results expected Dec 2026 (estimated)
- New cell injection trial targets tough cancers Results expected Feb 2027 (estimated)
- Experimental T-Cell therapy takes on advanced cancers Results expected Mar 2027 (estimated)
-
New cell injection trial targets tough cancers
Disease control Recruiting nowThis early-phase study tests a new cell therapy called GK01 in 10 people with advanced lung or esophageal cancer that no longer responds to standard treatments. The main goal is to check safety and how the body handles the therapy. Researchers will also look for early signs of tu…
Early phase 1 • Sponsor: Beijing Geekgene Technology Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can immune cells from belly fluid fight advanced cancer?
Disease control Recruiting nowThis early-phase trial tests a new treatment called GK02 for people with advanced solid tumors that cause fluid buildup in the belly (malignant ascites). The treatment uses the patient's own immune cells taken from that fluid, grown in a lab, and then given back. Only 9 participa…
Early phase 1 • Sponsor: Beijing Geekgene Technology Co., LTD • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC